Özet:

In this study, we aimed to evaluate the early results of n-butyl cyanoacrylate ablation (n-BSA) treatment and patient satisfaction using visual analogue scale (VAS) in the treatment of isolated great saphenous vein (GSV) insufficiency. 72 patients, in clinical degrees of C1-C4 according to the Comprehensive Classification System for Chronic Venous Disorders (CEAP), treated with n-BSA percutaneous endovenous embolization in January 2016 to July 2017 due to GSV incompetence, with GSV diameter between 6-9 mm and a reflux time of > 0.5 seconds, were enrolled in the study. Preoperative and postoperative 1 and 6 month evaluations were made using VAS and venous color duplex ultrasonography (CDUS). All data were evaluated retrospectively via patient files. Friedman test was used for statistical analysis. Statistical significance was set at p < 0.05 for all analyses. Preoperative, 1 and 6 months VAS scores were 6,05, 1,8 and 1,66 respectively. The difference between postoperative 1 and 6 months was not significant (p>0.05), but the differences between preoperative and postoperative both 1 and 6 months scores were statistically significant (p<0.001). 1 and 6 month venous CDUS showed 97% and 95% GSV closure ratio respectively. Evaluation of early period results of n-BSA embolization treatment for isolated GSV incompetence with regard to patient satisfaction using VAS, shows significant positive relationship in preoperative and early period postoperative period. VAS can be used as an effective method to evaluate early period patient satisfaction with n-BSA method for isolated great saphenous vein treatment.

Anahtar Kelimeler: